About
Medic Life Sciences develops a CRISPR functional genomics platform combined with patient tumor-like 3D cancer models to identify biomarkers, synthetic lethality, and mutations important for novel cancer drug development.
Explore Medic Life Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.